Metformin-related lactic acidosis in patients with acute kidney injury

International Urology and Nephrology

Volumn 43, Issue 4, 2011, Pages 1243-1248

  Devetzis, Vassilios ^a   Passadakis, Ploumis ^a   Panagoutsos, Stelios ^a   Theodoridis, Marios ^a   Thodis, Elias ^a   Georgoulidou, Anastasia ^a   Vargemezis, Vassilis ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

Author keywords

Acute kidney injury; Dialysis; Lactic acidosis; Metformin

Indexed keywords

AMLODIPINE; BICARBONATE; DICLOFENAC; ENALAPRIL; FUROSEMIDE; GLIMEPIRIDE; HYDROCHLOROTHIAZIDE; INSULIN; ISOTONIC SOLUTION; METFORMIN; OLMESARTAN; REPAGLINIDE; ANTIDIABETIC AGENT;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ADULT; AGED; ANAMNESIS; ANOREXIA; ARTICLE; BREATHING DISORDER; CASE REPORT; CHRONIC KIDNEY DISEASE; COMA; DIARRHEA; DISORIENTATION; DIURESIS; FEMALE; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HEMOFILTRATION; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY FUNCTION TEST; KNEE INJURY; LACTIC ACIDOSIS; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; OLIGURIA; PARATHYROID CARCINOMA; PHYSICAL EXAMINATION; SOMNOLENCE; VOMITING; CHEMICALLY INDUCED DISORDER; DRUG CONTRAINDICATION; MIDDLE AGED; RENAL REPLACEMENT THERAPY;

ACIDOSIS, LACTIC; ACUTE KIDNEY INJURY; AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; METFORMIN; MIDDLE AGED; RENAL DIALYSIS;

EID: 84859935146     PISSN: 03011623     EISSN: 15732584     Source Type: Journal    
DOI: 10.1007/s11255-010-9845-1     Document Type: Article

References (50)

1. Burton David Rose TWP (2001) Metabolic acidosis. In: Wonsciewicz M MK, Davis K (eds) Clinical physiology of acid-base and electrolyte disorders. McGraw-Hill, New York, pp 592-599
2. Bailey CJ, Turner RC (1996) Metformin. N Engl J Med 334:574-579
3. DeFronzo RA, Barzilai N, Simonson DC (1991) Mecha-nism of metformin action in obese and lean noninsulin-dependent diabetic subjects. J Clin Endocrinol Metab 73:1294-1301
4. Cusi K, Consoli A, DeFronzo RA (1996) Metabolic effects of metformin on glucose and lactate metabolism in non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 81:4059-4067
5. Stang M, Wysowski DK, Butler-Jones D (1999) Incidence of lactic acidosis in metformin users. Diabetes Care 22:925-927
6. Misbin RI, Green L, Stadel BV et al (1998) Lactic acidosis in patients with diabetes treated with metformin. N Engl J Med 338:265-266
7. Peters N, Jay N, Barraud D et al (2008) Metformin-associ-ated lactic acidosis in an intensive care unit Crit Care 12:R149
8. Naranjo CA, Busto U, Sellers EM et al (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30:239-245
9. UK Prospective Diabetes Study (UKPDS) Group (1998) Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 dia-betes (UKPDS 34). Lancet 352:854-865
10. Nathan DM, Buse JB, Davidson MB et al (2009) Medical management of hyperglycemia in type 2 diabetes: a con-sensus algorithm for the initiation and adjustment of ther-apy: a consensus statement of the American diabetes association and the european association for the study of diabetes. Diabetes Care 32:193-203
11. Misbin RI (2004) The phantom of lactic acidosis due to met-formin inpatients with diabetes. Diabetes Care 27:1791-1793
12. Salpeter SR, Greyber E, Pasternak GA et al (2003) Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus: systematic review and meta-analysis. Arch Intern Med 163:2594-2602
13. SalpeterS, GreyberE, PasternakGetal. (2006) Riskoffatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus. Cochrane Database Syst Rev:CD002967
14. DeFronzo RA, Goodman AM (1995) Efficacy of metfor-min in patients with non-insulin-dependent diabetes mel-litus. The multicenter metformin study group. N Engl J Med 333:541-549
15. Stumvoll M, Nurjhan N, Perriello G et al (1995) Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 333:550-554
16. Czyzyk A, Lao B, Bartosiewicz W et al (1978) The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects. Diabetologia 14:89-94
17. Glucophage-prescribing information. (2009) Bristol-Ma-yers Squibb, Princeton, NJ 08543, USA
18. Emslie-Smith AM, Boyle DI, Evans JM et al (2001) Contraindications to metformin therapy in patients with type 2 diabetes-a population-based study of adherence to prescribing guidelines. Diabet Med 18:483-488
19. Guo PY, Storsley LJ, Finkle SN (2006) Severe lactic aci-dosis treated with prolonged hemodialysis: recovery after massive overdoses of metformin. Semin Dial 19:80-83
20. von Mach MA, Sauer O, Sacha Weilemann L (2004) Experiences of a poison center with metformin-associated lactic acidosis. Exp Clin Endocrinol Diabetes 112:187-190
21. Chang CT, Chen YC, Fang JT et al (2002) Metformin-associated lactic acidosis: case reports and literature review. J Nephrol 15:398-402
22. Runge S, Mayerle J, Warnke C et al (2008) Metformin-asso-ciated lactic acidosis in patients with renal impairment solely due to drug accumulation? Diabetes Obes Metab 10:91-93
23. Lalau JD, Lacroix C, Compagnon P et al (1995) Role of metformin accumulation in metformin-associated lactic acidosis. Diabetes Care 18:779-784
24. Davidoff F (1971) Effects of guanidine derivatives on mitochondrial function. 3. The mechanism of phenethyl-biguanide accumulation and its relationship to in vitro respiratory inhibition. J Biol Chem 246:4017-4027
25. Owen MR, Doran E, Halestrap AP (2000) Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Bio-chem J 348(Pt 3):607-614
26. Dykens JA, Jamieson J, Marroquin L et al (2008) Bigua-nide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro. Toxicol Appl Pharmacol 233:203-210
27. Brunmair B, Staniek K, Gras F et al (2004) Thiazolidin-ediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 53:1052-1059
28. Irsigler K, Kritz H, Regal H et al (1979) Biguanide-induced and -associated lactic acidosis: serum and tissue biguanide levels in hyperlactaemia and lactic acidosis (author's transl). Wien Klin Wochenschr 91:59-65
29. Perrone J, Phillips C, Gaieski D (2008) Occult Metformin Toxicity in Three Patients with Profound Lactic Acidosis. J Emerg Med. doi:10.1016/j. jemermed.2007.11.055
30. Pentikainen PJ, Neuvonen PJ, Penttila A (1979) Pharma-cokinetics of metformin after intravenous and oral administration to man. Eur J Clin Pharmacol 16:195-202
31. Bellomo R, Ronco C, Kellum JA et al (2004) Acute renal failure\-definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 8:R204-R212
32. Mehta RL, Kellum JA, Shah SV et al (2007) Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11:R31
33. Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417-430
34. Liano F, Pascual J (1996) Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Madrid acute renal failure study group. Kidney Int 50:811-818
35. John Feehally JF, Johnson Richard J (2007) Comprehen-sive clinical nephrology. MOSBY Elsevier, Philadelphia
36. Luft D, Schmulling RM, Eggstein M (1978) Lactic aci-dosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia 14:75-87
37. Shenoy C (2006) Metformin-associated lactic acidosis precipitated by acute renal failure. Am J Med Sci 331: 55-57
38. Spiller HA, Sawyer TS (2006) Toxicology of oral antidi-abetic medications. Am J Health Syst Pharm 63:929-938
39. Lalau JD, Andrejak M, Moriniere P et al (1989) Hemodi-alysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int J Clin Pharmacol Ther Toxicol 27:285-288
40. Barrueto F, Meggs WJ, Barchman MJ (2002) Clearance of metformin by hemofiltration in overdose. J Toxicol Clin Toxicol 40:177-180
41. Heaney D, Majid A, Junor B (1997) Bicarbonate hae-modialysis as a treatment of metformin overdose. Nephrol Dial Transplant 12:1046-1047
42. Lalau JD, Westeel PF, Debussche X et al (1987) Bicar-bonate haemodialysis: an adequate treatment for lactic acidosis in diabetics treated by metformin. Intensive Care Med 13:383-387
43. Panzer U, Kluge S, Kreymann G et al (2004) Combination of intermittent haemodialysis and high-volume continuous haemofiltration for the treatment of severe metformin-induced lactic acidosis. Nephrol Dial Transplant 19: 2157-2158
44. Seidowsky A, Nseir S, Houdret N et al. (2009) Metformin-associated lactic acidosis: a prognostic and therapeutic study*. Crit Care Med 37(7):2312-2313
45. Arroyo AM, Walroth TA, Mowry JB et al. (2010) The MALAdy of metformin poisoning: is CVVH the cure? Am J Ther 17(1):96-100
46. Barton IK, Streather CP, Hilton PJetal(1991) Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid. Nephrol Dial Transplant 6:368-370
47. Silvestre J, Carvalho S, Mendes V et al (2007) Metformin-induced lactic acidosis: a case series. J Med Case Reports 1:126
48. Alivanis P, Giannikouris I, Paliuras C et al (2006) Met-formin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther 28:396-400
49. Teale KF, Devine A, Stewart H et al (1998) The man-agement of metformin overdose. Anaesthesia 53:698-701
50. Friesecke S, Abel P, Kraft M et al (2006) Combined renal replacement therapy for severe metformin-induced lactic acidosis. Nephrol Dial Transplant 21:2038-2039